CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc. (Nasdaq: ALKS) today reported unaudited financial results for its fiscal year ended March 31, 2007. The company is providing unaudited financial results while in discussions with the Staff of the Securities and Exchange Commission (the Staff) regarding its accounting for the VIVITROL® collaboration with Cephalon, Inc. (Cephalon). Alkermes received the request for information from the Staff during a periodic review of its Exchange Act filings. For more information, please refer to the Form 12b-25 filed by the company today.
